Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.
Yamamoto N, Tamura T, Yamamoto N, Yamada K, Yamada Y, Nokihara H, Fujiwara Y, Takahashi T, Murakami H, Boku N, Yamazaki K, Puchalski TA, Shin E. Yamamoto N, et al. Among authors: boku n. Cancer Chemother Pharmacol. 2009 Nov;64(6):1165-72. doi: 10.1007/s00280-009-0979-8. Epub 2009 Mar 24. Cancer Chemother Pharmacol. 2009. PMID: 19308410 Clinical Trial.
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL. Shirao K, et al. Among authors: boku n. J Clin Oncol. 2004 Sep 1;22(17):3466-74. doi: 10.1200/JCO.2004.05.017. Epub 2004 Jul 26. J Clin Oncol. 2004. PMID: 15277535 Clinical Trial.
[IFL].
Yamazaki K, Yoshino T, Boku N. Yamazaki K, et al. Among authors: boku n. Gan To Kagaku Ryoho. 2006 Jul;33(7):907-10. Gan To Kagaku Ryoho. 2006. PMID: 16835478 Review. Japanese.
A late phase II study of S-1 for metastatic pancreatic cancer.
Okusaka T, Funakoshi A, Furuse J, Boku N, Yamao K, Ohkawa S, Saito H. Okusaka T, et al. Among authors: boku n. Cancer Chemother Pharmacol. 2008 Apr;61(4):615-21. doi: 10.1007/s00280-007-0514-8. Epub 2007 May 23. Cancer Chemother Pharmacol. 2008. PMID: 17520253 Clinical Trial.
511 results